Delivery Order SPE2DR25D2011-SPE2DR26FADMF
- Not listed
- The Defense Logistics Agency awarded a $2,280.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injectors, with an ultimate completion date of November 28, 2025. This non-set-aside contract was awarded competitively on November 26, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, valued at $1,041.42. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,964.30 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in the same city. REPATHA is a prescription...
- The Defense Logistics Agency awarded a $17,662.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 12, 2025. This non-competitive delivery order was issued on November 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to treat high cholesterol and reduce cardiovascular risk in eligible...
- The Defense Logistics Agency awarded a delivery order valued at $4,115.11 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed-price delivery order represents a non-competitive procurement and is being fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to lower cholesterol levels and reduce cardiovascular...
- The Defense Logistics Agency awarded a $2,455.27 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors. This firm fixed price, non-set-aside contract was awarded on October 23, 2025, with an ultimate completion date of October 24, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,214.99 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to lower cholesterol levels and...
- The Defense Logistics Agency awarded a delivery order valued at $10,447.89 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors on October 28, 2025, with an ultimate completion date of October 29, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania headquarters. The award represents a competitive procurement under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,157.40 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 23, 2025. This non-competitive delivery order represents a firm fixed-price transaction executed on October 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. REPATHA is a PCSK9 inhibitor prescribed for patients with high cholesterol and...
- The Defense Logistics Agency awarded a delivery order valued at $7,425.26 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 19, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The...
- SPE2DR25D2011Indefinite Delivery Contract
- SPE2DR25D2011-SPE2DR26FADMFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $47,292.82 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed-price, competitively awarded delivery order was executed on December 2, 2025, with an ultimate completion date of December 3, 2025. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. REPATHA is a prescription medication used for cholesterol management and cardiovascular disease prevention, and the auto-injector formulation enables patient self-administration for chronic disease management within military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement extending through December 2026 that supports global pharmaceutical supply to military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, and specialized medical devices across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $47.3k | 12/1/25 |